DHDerek Barrry Hennessey

Derek Barrry Hennessey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Derek Barrry Hennessey has a total of 152 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bacillus Calmette-Guérin therapy in the management of upper tract urothelial carcinoma in-situ: a systematic review

    by Youssef Garras, Daniah Alsaadi, Ned Kinnear, Derek Hennessey

    Background: Upper urinary tract carcinoma in-situ (UUT-CIS) is an aggressive disease traditionally managed with radical nephroureterectomy (RNU), often resulting in loss of renal function. Topical Bacillus Calmette-Guérin (BCG) therapy has been explored as a kidney-sparing alternative, although evidence remains limited and heterogeneous. This review aimed to synthesise oncological and safety outcomes of topical BCG therapy for UUT-CIS. Methods: A systematic search of PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and grey literature (registration No. CRD420261277998). Eligible studies were published 01/01/2000–14/09/25, enrolled adult patients with UUT-CIS treated with topical BCG and reported oncological or toxicity outcomes. Primary outcomes were rates of complete response, recurrence and progression. Where methodological homogeneity permitted, meta-analysis was planned. Risk of bias was assessed using Risk Of Bias In Non-randomised Studies of Interventions (ROBINS)-I V2. Results: Fourteen observational studies comprising 298 renal units (267 patients) were included (weighted mean age of 71.8 years; 19.2% female). Complete response rates following BCG induction ranged 59–100% per renal unit. Recurrence rates after initial response ranged 0–70% and progression rates ranged 0–43%. The proportion of renal units requiring salvage RNU ranged 0–25%. Renal unit preservation ranged 45–100%. Median follow-up varied substantially at 13–88 months. Adverse events were predominantly local and self-limited; severe systemic toxicity was uncommon, and treatment-related mortality was reported in one patient. Substantial heterogeneity existed in follow-up duration, delivery technique, surveillance protocols, and outcome definitions, negating meta-analysis. Most included studies demonstrated a moderate risk of bias across key ROBINS-I domains, reflecting observational study design and the absence of randomized trials. Conclusions: Topical BCG therapy for UUT-CIS is associated with high initial response rates and meaningful renal preservation and may represent a kidney-sparing option in carefully selected or imperative clinical scenarios. However, recurrence and progression rates remain variable. Topical BCG therapy should not be considered equivalent to RNU, which remains the oncological standard of care.


  • Open Access

    Patient needs and preferences for a kidney stone self-monitoring app: a pilot survey analysis

    by Duaa Tahir Mahmood, Helen L. Richards, Derek B. Hennessey

    Nutritional habits play a role in the formation and recurrence of kidney stone disease (KSD). Dietary modification is important for the prevention of KSD recurrence. Mobile health (mHealth) applications (apps) may help patients manage their condition by offering personalised dietary guidance and tracking intake. This study assesses the interest of patients with recurrent kidney stone disease (KSD) in a self-monitoring app and identifies key features to guide its development. This cross-sectional quantitative study used an online survey to collect data from KSD patients. The survey collected information on patient demographics, healthcare smartphone usage, and preferences for app features. The findings will inform the development of an initial app prototype. Fifty-five patients participated (58.2% male; most aged 35–54). Kidney stone recurrence ranged from one episode (34.5%) to six or more (9.1%). Health app use varied: 29.1% used them daily, 36.4% never used them. While 30.9% were aware of relevant risk factors, most (61.8%) had only partial awareness. High concern about recurrence (65.5%) significantly predicted the likelihood of app use ( p < 0.01). Interest in a prevention app was strong, with 72.8% indicating they were likely to use it. The likelihood of use was strongly correlated with recommending the app ( p < 0.001), although recurrence frequency was not associated with interest. The top desired features included water tracking (81.1%), dietary advice (77.4%), educational content (56.6%), and diet tracking (56.6%). Participants prioritised hydration, diet, and personalised education, with 36.4% favouring tailored recommendations. This pilot survey highlights the strong interest of patients in a mobile health (mHealth) app for dietary self-monitoring in KSD. Larger studies, feasibility testing, and future trials will be needed to evaluate effectiveness, cost, and real-world implementation.

  • To investigate the current evidence in post-operative outcomes to support the use of robotic-assisted laparoscopic (radical) prostatectomy (RALP) over laparoscopic radical prostatectomy (LRP) in cases of organ-confined prostate cancer

    by Jack S. McDermott, Gavin Calpin, Ashwini Tittawella, Derek Hennessey, Fardod O’kElly

    To investigate the current evidence in post-operative outcomes to support the use of Robotic-Assisted Laparoscopic (radical) Prostatectomy (RALP) over Laparoscopic Radical Prostatectomy (LRP) in cases of organ-confined prostate cancer. A systematic review was performed according to PRISMA/MOOSE guidelines. Dichotomous variables were pooled as risk ratios (RR). Continuous variables were pooled as weighted mean differences (WMD). Quality assessment was performed using the Newcastle-Ottawa score (NOS). Four suitable randomised controlled studies were identified from the literature. 1026 male patients with prostate cancer (LRP n = 342, 33.33%; RALP n = 684, 66.67%) were identified as eligible for inclusion. These patients were randomised for definitive operative management to RALP or LRP. There was no statistically significant difference identified in operative time (MD -2.81, 95% CI -12.92–7.31, I2 = 77%, P = 0.59). There was no statistically significant difference identified in operative blood-loss (MD -9.34, 95% CI -55.81 + 37.12, I2 = 77%, P = 0.69). There was no statistically significant difference identified in biochemical recurrence free rates at 12 months. Statistically significant differences were identified in meta-analysis of post-operative urinary continence, and post-operative potency. These favoured RALP over LRP. No statistically significant difference was identified in operative time, operative blood-loss, or biochemical recurrence free rates at 12 months. There is an statistically significant improved post-operative profile of patients having undergone RALP v LRP, in particular with respect to return of sexual function and urinary continence. There was no statistical difference identified in intra-operative blood-loss, perioperative complications, or operative time.

  • Performance of percutaneous core biopsy in predicting renal tumour pathology: a systematic review

    by Rebecca Stokes, Derek Hennessey, Ned Kinnear

    Objectives: To systematically assess the diagnostic accuracy of renal tumour core biopsy for detecting malignancy in adults with localised renal masses. Materials and Methods: A search of the Cochrane, Embase and Medline databases and the grey literature published up to September 2024 was performed using pre‐published methods. Eligible studies were published in English, reported all true‐ and false‐positive and ‐negative results for localised renal tumour core biopsies in unique adult cohorts, and used surgical histology as the reference standard. Studies were excluded if they exclusively reported patients with malignant biopsy or surgical histology. Primary outcomes were biopsy sensitivity and specificity for detecting malignancy. Results: Twenty‐one non‐randomised cohorts were identified, totalling 1735 unique patients. In detecting malignancy, renal tumour core biopsy had a weighted mean sensitivity of 98% (95% confidence interval [CI] 0.96–1.00) and specificity of 94% (95% CI 0.84–1.00). Secondary outcomes were determined, including mean false‐positive rate (6%), false‐negative rate (2%), non‐diagnostic rate on first (8%) and second biopsy attempt (9%), and concordance of tumour sub‐type (92%) and Fuhrmann grade, both exact grade (60%) and simplified low/high grade (79%). Summary receiver‐operating characteristic curve analysis demonstrated high test accuracy (area under the curve 0.97). Risk of bias was moderate to high for most studies. Conclusion: Core biopsy for renal masses in adults has high specificity and sensitivity. Excluding patients for whom biopsy will not change management, near‐routine renal tumour biopsy may reduce rates of nephrectomy for ultimately benign tumours, and optimise operating theatre utilisation.


  • Open Access

    A case report of minimally invasive management of congenital retrocaval ureter

    by Orna T Cantillon, Ibrahim Haidaran, Ned Kinnear, Derek B Hennessey

    Retrocaval ureter (RU) is a rare congenital malformation where the ureteric pathway is altered, passing posteriorly around the inferior vena cava (IVC). Occasionally, this leads to the IVC compressing the ureter, resulting in obstruction. In this report, we discuss a male who presented with severe right-sided flank pain and was otherwise well with no significant medical, urological, or birth history. Initial imaging revealed severe right-sided hydroureter with distinct obstruction point, and likely RU. Anecdotal and small centre cases of acute management and laparoscopic RU repair were reviewed. Initial management focused on pain control requiring a nephrostomy with subsequent transperitoneal laparoscopic dissection and repair. Operative time was 138 min with 50 mL blood loss. Post-operatively the patient recovered well and was symptom free at 6 month follow up ultrasound. Similarly, most reviewed cases chose a trans-peritoneal laparoscopic approach with good outcomes.


  • Open Access

    An examination of the quality of kidney stone information on YouTube and TikTok

    by Zuzanna Augustyn, Helen L Richards, Alice McGrath, Yvonne Swanton, Derek B Hennessey

    Social media is increasingly consulted by patients for health-related information. The quality of this information is unknown and unregulated. This study aimed to investigate the quality of kidney stones information on two popular video platforms, YouTube and TikTok, and examine factors related to its quality. A search using keywords of “kidney stones” alongside “information, prevention, treatment” was used across YouTube and TikTok. The top 50 videos on each platform were rated by 4 independent reviewers on: general information, epidemiology, symptoms/presentation, treatment, and prevention. The American Urological Association’s kidney stone curriculum was utilised as the benchmark for quality. The total number of views across the 100 videos was over 46 million. Overall, 91% of videos were educational in terms of genre. Misinformation was present in 34% of TikTok and 2% of YouTube videos. YouTube received significantly higher quality ratings across all parameters bar prevention (z’s>-4.79 p’s < 0.001); however, less than 50% of YouTube videos were rated as good quality. There was no association between quality and the number of likes or views across platforms (p’s > 0.3). The quality of information presented across platforms was very variable with over half of videos considered poor quality. Given the high usage of social media as a source of health information it is important that healthcare providers and the general public are aware of the limits of information available on both platforms and continued efforts are made to develop high quality videos suitable for patient consumption.


  • Open Access

    Using artificial intelligence to generate medical literature for urology patients: a comparison of three different large language models

    by David Pompili, Yasmina Richa, Patrick Collins, Helen Richards, Derek B Hennessey

    Purpose: Large language models (LLMs) are a form of artificial intelligence (AI) that uses deep learning techniques to understand, summarize and generate content. The potential benefits of LLMs in healthcare is predicted to be immense. The objective of this study was to examine the quality of patient information leaflets (PILs) produced by 3 LLMs on urological topics. Methods: Prompts were created to generate PILs from 3 LLMs: ChatGPT-4, PaLM 2 (Google Bard) and Llama 2 (Meta) across four urology topics (circumcision, nephrectomy, overactive bladder syndrome, and transurethral resection of the prostate). PILs were evaluated using a quality assessment checklist. PIL readability was assessed by the Average Reading Level Consensus Calculator. Results: PILs generated by PaLM 2 had the highest overall average quality score (3.58), followed by Llama 2 (3.34) and ChatGPT-4 (3.08). PaLM 2 generated PILs were of the highest quality in all topics except TURP and was the only LLM to include images. Medical inaccuracies were present in all generated content including instances of significant error. Readability analysis identified PaLM 2 generated PILs as the simplest (age 14–15 average reading level). Llama 2 PILs were the most difficult (age 16–17 average). Conclusion: While LLMs can generate PILs that may help reduce healthcare professional workload, generated content requires clinician input for accuracy and inclusion of health literacy aids, such as images. LLM-generated PILs were above the average reading level for adults, necessitating improvement in LLM algorithms and/or prompt design. How satisfied patients are to LLM-generated PILs remains to be evaluated.


  • The STING in the tale of Teflon®: Delayed ureteric obstruction after subureteric transurethral injection with polytetrafluoroethylene paste for vesicoureteral reflux

    by Matthew Murphy, Lorraine Scanlon, Mutaz Elamin, Charles O'Connor, Nick Mayer, Ciaran Brady, Derek Hennessey

  • Open Access

    Treatment of urge incontinence in postmenopausal women: A systematic review

    by Rawa Bapir, Kamran Hassan Bhatti, Ahmed Eliwa, Herney Andrés García-Perdomo, Nazim Gherabi, Derek Hennessey, Vittorio Magri, Panagiotis Mourmouris, Adama Ouattara, Gianpaolo Perletti, et al.

    Background: Urinary incontinence and other urinary symptoms tend to be frequent at menopause because of hormonal modifications and aging. Urinary symptoms are associated with the genitourinary syndrome of menopause which is characterized by physical changes of the vulva, vagina and lower urinary tract. The treatment strategies for postmenopausal urinary incontinence are various and may include estrogens, anticholinergics, and pelvic floor muscle training. A comparison of these treatments is difficult due to the heterogeneity of adopted protocols. We systematically reviewed the evidence from randomized controlled trials (RCTs) focusing on treatment of postmenopausal women with urge incontinence. Methods: We conducted a systematic review and meta-analysis by searching PubMed and EMBASE databases for randomized controlled trials (RCTs) reporting results of treatments for postmenopausal urinary urge incontinence. Odds ratios for improvement of urinary incontinence were calculated using random effect Mantel-Haenszel statistics. Results: Out of 248 records retrieved, 35 eligible RCTs were assessed for risk of bias and included in the meta-analysis. Compared with placebo, systemic estrogens were associated with decreased odds of improving urinary incontinence in postmenopausal women (OR = 0.74, 95% CI: 0.61-0.91, 7 series, 17132 participants, Z = 2.89, P = 0.004, I2 = 72%). In most studies, no significant improvement in urinary symptoms was observed in patients treated with local estrogens, although they showed to be helpful in improving vaginal symptoms. Vitamin D, phytoestrogens and estrogen modulators were not effective in improving symptoms of incontinence and other symptoms of genitourinary menopause syndrome or yielded contradictory results. A randomized controlled trial demonstrated that oxybutynin was significantly better than placebo at improving postmenopausal urgency and urge incontinence. The combination of anticholinergics with local estrogens has not been shown to be more effective than anticholinergics alone in improving urinary incontinence symptoms in postmenopausal women. Physical therapy showed an overall positive outcome on postmenopausal urinary incontinence symptoms, although such evidence should be further validated in the frame of quality RCTs. Conclusions: The evidence for effective treatment of postmenopausal urinary incontinence is still lacking. Welldesigned large studies having subjective and objective improvement primary endpoints in postmenopausal urinary incontinence are needed. At present, a combination of different treatments tailored to the characteristics of the individual patient can be suggested.